Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex N Bullock

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
ACS Medicinal Chemistry Letters|August 14, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
The EMBO Journal|July 21, 2018
Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signalingMatous Hrdinka, Lisa Schlicher, Bing Dai, et al.
ACS Chemical Biology|August 1, 2013
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitorHyung-Gu Kim, Li Tan, Ellen L Weisberg, et al.
Journal of Medicinal Chemistry|March 18, 2024
Discovery of Conformationally Constrained ALK2 InhibitorsHéctor González-Álvarez, Deeba Ensan, Tao Xin, et al.
Science (New York, N.Y.)|March 30, 2013
The structural basis of ZMPSTE24-dependent laminopathiesAndrew Quigley, Yin Yao Dong, Ashley C W Pike, et al.
Journal of Medicinal Chemistry|May 6, 2020
Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine GliomaDeeba Ensan, David Smil, Carlos A Zepeda-Velázquez, et al.
Journal of Medicinal Chemistry|August 5, 2018
Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2Zhen Wang, Yali Zhang, Daniel M Pinkas, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
A Potent and Selective CDKL5/GSK3 Chemical Probe is NeuroprotectiveHan Wee Ong, Yi Liang, William Richardson, et al.
JCI Insight|March 11, 2021
Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressivaEleanor Williams, Jana Bagarova, Georgina Kerr, et al.
ACS Chemical Neuroscience|April 21, 2023
Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is NeuroprotectiveHan Wee Ong, Yi Liang, William Richardson, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
ACS Medicinal Chemistry Letters|August 14, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
The EMBO Journal|July 21, 2018
Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signalingMatous Hrdinka, Lisa Schlicher, Bing Dai, et al.
ACS Chemical Biology|August 1, 2013
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitorHyung-Gu Kim, Li Tan, Ellen L Weisberg, et al.
Journal of Medicinal Chemistry|March 18, 2024
Discovery of Conformationally Constrained ALK2 InhibitorsHéctor González-Álvarez, Deeba Ensan, Tao Xin, et al.
Science (New York, N.Y.)|March 30, 2013
The structural basis of ZMPSTE24-dependent laminopathiesAndrew Quigley, Yin Yao Dong, Ashley C W Pike, et al.
Journal of Medicinal Chemistry|May 6, 2020
Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine GliomaDeeba Ensan, David Smil, Carlos A Zepeda-Velázquez, et al.
Journal of Medicinal Chemistry|August 5, 2018
Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2Zhen Wang, Yali Zhang, Daniel M Pinkas, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
A Potent and Selective CDKL5/GSK3 Chemical Probe is NeuroprotectiveHan Wee Ong, Yi Liang, William Richardson, et al.
JCI Insight|March 11, 2021
Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressivaEleanor Williams, Jana Bagarova, Georgina Kerr, et al.
ACS Chemical Neuroscience|April 21, 2023
Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is NeuroprotectiveHan Wee Ong, Yi Liang, William Richardson, et al.
Pageof 12